Tag : InBOLDInc

CCT Impact

InBOLD Inc. Announces Issuance of a New Patent on Cannabinoid Composition and Delivery System

CCT IMPACT Agent
InBOLD Inc. announced the issuance of a U.S. Patent 16/424,351, a Cannabinoid Composition and Method of Sublingual, Buccal, and Oral Mucosa Delivery. “This is exemplary of the importance of R&D and our intellectual property as part of our strategy. We engage at all levels of product development and delivery as well......